4xue
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 4xue is ON HOLD Authors: Allison, T., Wolkenberg, S., Sanders, J.M., Soisson, S.M. Description: Synthesis and evaluation of heterocyclic catechol m...) |
|||
| (6 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of catechol-O-methyltransferase (COMT): Structure with Cmpd27b== | |
| + | <StructureSection load='4xue' size='340' side='right'caption='[[4xue]], [[Resolution|resolution]] 2.30Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4xue]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4XUE OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4XUE FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=43J:2-(BIPHENYL-3-YL)-5-HYDROXY-3-METHYLPYRIMIDIN-4(3H)-ONE'>43J</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=SAM:S-ADENOSYLMETHIONINE'>SAM</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4xue FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4xue OCA], [https://pdbe.org/4xue PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4xue RCSB], [https://www.ebi.ac.uk/pdbsum/4xue PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4xue ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/COMT_HUMAN COMT_HUMAN] Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol. | ||
| - | + | ==See Also== | |
| - | + | *[[Catechol O-methyltransferase 3D structures|Catechol O-methyltransferase 3D structures]] | |
| - | + | __TOC__ | |
| - | [[Category: | + | </StructureSection> |
| - | [[Category: Allison | + | [[Category: Homo sapiens]] |
| - | [[Category: Sanders | + | [[Category: Large Structures]] |
| - | [[Category: Soisson | + | [[Category: Allison T]] |
| - | [[Category: Wolkenberg | + | [[Category: Sanders JM]] |
| + | [[Category: Soisson SM]] | ||
| + | [[Category: Wolkenberg S]] | ||
Current revision
Synthesis and evaluation of heterocyclic catechol mimics as inhibitors of catechol-O-methyltransferase (COMT): Structure with Cmpd27b
| |||||||||||
